Novel adenosine deaminase 2 mutations in a child with a fatal vasculopathy

Eur J Pediatr. 2014 Jun;173(6):827-30. doi: 10.1007/s00431-014-2320-8. Epub 2014 Apr 16.

Abstract

Adenosine deaminase 2 (ADA2) deficiency due to CECR1 mutations is a recently defined disorder that involves systemic inflammation and vasculopathy often associated with polyarteritis nodosa. We report on a 5-year-old girl with a severe vasculopathy who carried two novel mutations in CECR1.

Conclusion: Identification of CECR1 mutations in patients with vasculopathy may lead to earlier diagnosis of ADA2 deficiency.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Deaminase / deficiency
  • Adenosine Deaminase / genetics*
  • Child
  • Child, Preschool
  • Diagnosis, Differential
  • Female
  • Humans
  • Intercellular Signaling Peptides and Proteins / deficiency
  • Intercellular Signaling Peptides and Proteins / genetics*
  • Mutation*
  • Polyarteritis Nodosa / diagnosis
  • Polyarteritis Nodosa / genetics*

Substances

  • Intercellular Signaling Peptides and Proteins
  • ADA2 protein, human
  • Adenosine Deaminase